Rosie Charles
Research Subjects
Rosie Charles has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Phil Tittensor
The Royal Wolverhampton NHS Trust, Wolverhampton, UK
5 shared publications - Amberly Brigden
School of Engineering Mathematics and Technology, University of Bristol, Bristol, United Kingdom
4 shared publications - Emily E. V. Quilter
School of Engineering Mathematics and Technology, University of Bristol, Bristol, United Kingdom
4 shared publications - Leandro Junges
Centre for Systems Modelling and Quantitative Biomedicine, University of Birmingham, Birmingham, United Kingdom
4 shared publications - Liz Stuart
School of Computing, Ulster University, Belfast, United Kingdom
4 shared publications - Peter Kissack
School of Mathematics, College of Engineering and Physical Sciences, University of Birmingham, Birmingham, B15 2TT, UK
4 shared publications
Latest Publications
- 28 May 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 182, 111140
Nurse led first seizure clinics-a dangerous experiment or an effective alternative to the norm?
- 28 May 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 182, 111140
Nurse led first seizure clinics-a dangerous experiment or an effective alternative to the norm?
- Open Access
- 20 March 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15 (1) , e85993
A Digital Intervention for Capturing Real-Time Health Data for Epilepsy Seizure Forecasting: Protocol for the ATMOSPHERE Study
Background: Epilepsy is a chronic neurological disorder marked by recurrent and apparently unpredictable seizures and associated with premature death, injury, and diminished quality of life. The unpredictability of seizures is a major concern for people with epilepsy. Thus, developing tools for seizure prediction is a research priority. The Artificial Intelligence to Optimise Seizure Prediction to Empower People With Epilepsy (ATMOSPHERE) project focuses on the development and evaluation of seizure forecasting technology involving mobile technology and machine learning to provide personalized seizure forecasting (risk of seizure in the near future). The project is informed by complex intervention frameworks, which recommend phases of development, feasibility study, clinical evaluation, and implementation. Objective: Objective 1 aims to conduct a feasibility study to test and refine the trial methods for a future clinical trial. Objective 2 aims to test and refine the data collection technology, considering usability and technical performance. Objective 3 aims to collect longitudinal data on seizures and their precipitants to refine seizure forecasting. Methods: This study is a single-arm, mixed methods feasibility study, testing a prototype of the data collection technology, with phase 2 testing a minimum viable product. In total, 60 participants will be recruited via specialist National Health Service epilepsy clinics. Inclusion criteria are adults with epilepsy, experiencing seizures twice per month, able to consent, and engage with technology. Clinicians will screen and gain consent to contact, with researchers obtaining full consent. Participants will be invited to complete the following study procedures: (1) onboarding, (2) use the data collection technology (phase 1 or 2) in their lived context for up to 6 months, (3) complete patient-reported outcome measures and capture clinical-reported outcome measures at baseline and 3 months, and (4) complete a qualitative interview exploring their views of the data collection technology. A study flow diagram will report recruitment rates (outcome 1), diversity of the recruited sample (outcome 2), barriers and facilitators to recruitment (outcome 3), retention rates (outcome 4), and barriers and facilitators to retention (outcome 5). To assess the data collection technology, quantitative technology use data and qualitative interview data will be analyzed to assess usability (outcome 6) and technical performance (outcome 7) of the data collection technology. These outcomes will inform iterative minimum viable product development and testing cycles with stakeholders. Results: Recruitment is planned to begin in quarter 1 of 2026, with data collection expected to be completed by quarter 2 of 2027. Data analysis will take place during quarter 3, and the results will be published in quarter 4. Conclusions: This project aims to improve clinical outcomes for people with epilepsy through seizure forecasting technology. To evaluate clinical outcomes, robust trial methodology is critical. This feasibility study will optimize methods for a future full-scale clinical trial as well as refine the seizure forecasting intervention. International Registered Report Identifier (IRRID): PRR1-10.2196/85993
- 20 March 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15 (1) , e85993
Open AccessA Digital Intervention for Capturing Real-Time Health Data for Epilepsy Seizure Forecasting: Protocol for the ATMOSPHERE Study
Background: Epilepsy is a chronic neurological disorder marked by recurrent and apparently unpredictable seizures and associated with premature death, injury, and diminished quality of life. The unpredictability of seizures is a major concern for people with epilepsy. Thus, developing tools for seizure prediction is a research priority. The Artificial Intelligence to Optimise Seizure Prediction to Empower People With Epilepsy (ATMOSPHERE) project focuses on the development and evaluation of seizure forecasting technology involving mobile technology and machine learning to provide personalized seizure forecasting (risk of seizure in the near future). The project is informed by complex intervention frameworks, which recommend phases of development, feasibility study, clinical evaluation, and implementation. Objective: Objective 1 aims to conduct a feasibility study to test and refine the trial methods for a future clinical trial. Objective 2 aims to test and refine the data collection technology, considering usability and technical performance. Objective 3 aims to collect longitudinal data on seizures and their precipitants to refine seizure forecasting. Methods: This study is a single-arm, mixed methods feasibility study, testing a prototype of the data collection technology, with phase 2 testing a minimum viable product. In total, 60 participants will be recruited via specialist National Health Service epilepsy clinics. Inclusion criteria are adults with epilepsy, experiencing seizures twice per month, able to consent, and engage with technology. Clinicians will screen and gain consent to contact, with researchers obtaining full consent. Participants will be invited to complete the following study procedures: (1) onboarding, (2) use the data collection technology (phase 1 or 2) in their lived context for up to 6 months, (3) complete patient-reported outcome measures and capture clinical-reported outcome measures at baseline and 3 months, and (4) complete a qualitative interview exploring their views of the data collection technology. A study flow diagram will report recruitment rates (outcome 1), diversity of the recruited sample (outcome 2), barriers and facilitators to recruitment (outcome 3), retention rates (outcome 4), and barriers and facilitators to retention (outcome 5). To assess the data collection technology, quantitative technology use data and qualitative interview data will be analyzed to assess usability (outcome 6) and technical performance (outcome 7) of the data collection technology. These outcomes will inform iterative minimum viable product development and testing cycles with stakeholders. Results: Recruitment is planned to begin in quarter 1 of 2026, with data collection expected to be completed by quarter 2 of 2027. Data analysis will take place during quarter 3, and the results will be published in quarter 4. Conclusions: This project aims to improve clinical outcomes for people with epilepsy through seizure forecasting technology. To evaluate clinical outcomes, robust trial methodology is critical. This feasibility study will optimize methods for a future full-scale clinical trial as well as refine the seizure forecasting intervention. International Registered Report Identifier (IRRID): PRR1-10.2196/85993
- Open Access
- 16 February 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 177, 110925
Prioritising follow-up for people with suspected epilepsy using a digital EEG biomarker
- 16 February 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 177, 110925
Open AccessPrioritising follow-up for people with suspected epilepsy using a digital EEG biomarker
- Open Access
- 16 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
A Digital Intervention for Capturing Real-Time Health Data for Epilepsy Seizure Forecasting: Protocol for the ATMOSPHERE Study (Preprint)
BACKGROUND Epilepsy is a chronic neurological disorder marked by recurrent and apparently unpredictable seizures and associated with premature death, injury, and diminished quality of life. The unpredictability of seizures is a major concern for people with epilepsy. Thus, developing tools for seizure prediction is a research priority. The Artificial Intelligence to Optimise Seizure Prediction to Empower People With Epilepsy (ATMOSPHERE) project focuses on the development and evaluation of seizure forecasting technology involving mobile technology and machine learning to provide personalized seizure forecasting (risk of seizure in the near future). The project is informed by complex intervention frameworks, which recommend phases of development, feasibility study, clinical evaluation, and implementation. OBJECTIVE Objective 1 aims to conduct a feasibility study to test and refine the trial methods for a future clinical trial. Objective 2 aims to test and refine the data collection technology, considering usability and technical performance. Objective 3 aims to collect longitudinal data on seizures and their precipitants to refine seizure forecasting. METHODS This study is a single-arm, mixed methods feasibility study, testing a prototype of the data collection technology, with phase 2 testing a minimum viable product. In total, 60 participants will be recruited via specialist National Health Service epilepsy clinics. Inclusion criteria are adults with epilepsy, experiencing seizures twice per month, able to consent, and engage with technology. Clinicians will screen and gain consent to contact, with researchers obtaining full consent. Participants will be invited to complete the following study procedures: (1) onboarding, (2) use the data collection technology (phase 1 or 2) in their lived context for up to 6 months, (3) complete patient-reported outcome measures and capture clinical-reported outcome measures at baseline and 3 months, and (4) complete a qualitative interview exploring their views of the data collection technology. A study flow diagram will report recruitment rates (outcome 1), diversity of the recruited sample (outcome 2), barriers and facilitators to recruitment (outcome 3), retention rates (outcome 4), and barriers and facilitators to retention (outcome 5). To assess the data collection technology, quantitative technology use data and qualitative interview data will be analyzed to assess usability (outcome 6) and technical performance (outcome 7) of the data collection technology. These outcomes will inform iterative minimum viable product development and testing cycles with stakeholders. RESULTS Recruitment is planned to begin in quarter 1 of 2026, with data collection expected to be completed by quarter 2 of 2027. Data analysis will take place during quarter 3, and the results will be published in quarter 4. CONCLUSIONS This project aims to improve clinical outcomes for people with epilepsy through seizure forecasting technology. To evaluate clinical outcomes, robust trial methodology is critical. This feasibility study will optimize methods for a future full-scale clinical trial as well as refine the seizure forecasting intervention. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/85993
- 16 October 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Digital Intervention for Capturing Real-Time Health Data for Epilepsy Seizure Forecasting: Protocol for the ATMOSPHERE Study (Preprint)
BACKGROUND Epilepsy is a chronic neurological disorder marked by recurrent and apparently unpredictable seizures and associated with premature death, injury, and diminished quality of life. The unpredictability of seizures is a major concern for people with epilepsy. Thus, developing tools for seizure prediction is a research priority. The Artificial Intelligence to Optimise Seizure Prediction to Empower People With Epilepsy (ATMOSPHERE) project focuses on the development and evaluation of seizure forecasting technology involving mobile technology and machine learning to provide personalized seizure forecasting (risk of seizure in the near future). The project is informed by complex intervention frameworks, which recommend phases of development, feasibility study, clinical evaluation, and implementation. OBJECTIVE Objective 1 aims to conduct a feasibility study to test and refine the trial methods for a future clinical trial. Objective 2 aims to test and refine the data collection technology, considering usability and technical performance. Objective 3 aims to collect longitudinal data on seizures and their precipitants to refine seizure forecasting. METHODS This study is a single-arm, mixed methods feasibility study, testing a prototype of the data collection technology, with phase 2 testing a minimum viable product. In total, 60 participants will be recruited via specialist National Health Service epilepsy clinics. Inclusion criteria are adults with epilepsy, experiencing seizures twice per month, able to consent, and engage with technology. Clinicians will screen and gain consent to contact, with researchers obtaining full consent. Participants will be invited to complete the following study procedures: (1) onboarding, (2) use the data collection technology (phase 1 or 2) in their lived context for up to 6 months, (3) complete patient-reported outcome measures and capture clinical-reported outcome measures at baseline and 3 months, and (4) complete a qualitative interview exploring their views of the data collection technology. A study flow diagram will report recruitment rates (outcome 1), diversity of the recruited sample (outcome 2), barriers and facilitators to recruitment (outcome 3), retention rates (outcome 4), and barriers and facilitators to retention (outcome 5). To assess the data collection technology, quantitative technology use data and qualitative interview data will be analyzed to assess usability (outcome 6) and technical performance (outcome 7) of the data collection technology. These outcomes will inform iterative minimum viable product development and testing cycles with stakeholders. RESULTS Recruitment is planned to begin in quarter 1 of 2026, with data collection expected to be completed by quarter 2 of 2027. Data analysis will take place during quarter 3, and the results will be published in quarter 4. CONCLUSIONS This project aims to improve clinical outcomes for people with epilepsy through seizure forecasting technology. To evaluate clinical outcomes, robust trial methodology is critical. This feasibility study will optimize methods for a future full-scale clinical trial as well as refine the seizure forecasting intervention. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/85993
- Open Access
Prioritising Follow-Up for People with Suspected Epilepsy Using a Digital EEG Biomarker
Lengthy waits for follow-up testing are common for people with suspected epilepsy. This delays diagnosis, prolongs uncertainty and increases seizure risk. Initial EEGs are frequently inconclusive, yet follow-ups are often dictated by referral date, and there is no established method for risk-based prioritisation. Here, we tested whether an established digital EEG biomarker could help prioritise those most likely to have epilepsy for expedited follow-up EEG testing. We analysed 196 normal non-contributory (non-diagnostic) initial EEGs collected from six National Health Service (NHS) sites in England. From these recordings, we extracted eight previously validated computational features that quantify the likelihood that the EEG was recorded from someone with active epilepsy. We then used this information to reorder follow-up lists and compared outcomes against standard referral-based scheduling. We found that ordering for follow-up testing based upon the digital biomarker consistently prioritised people subsequently diagnosed with epilepsy; for a waitlist of 40 patients, the median number of follow-up EEGs needed to see 50% of true epilepsy patients was decreased by 6 (95% CI 4-7). The EEG diagnostic yield for epilepsy of follow-ups was increased relative to orderings based on time of referral (median increase in yield for epilepsy at 50% follow-up EEGs was 5%; 95 CI 4.9%-10%). Our study indicates that a routine EEG may furnish an objective risk metric that could accelerate second-line investigations and so reduce diagnostic delay whilst improving resource allocation in clinical practice.
Open AccessPrioritising Follow-Up for People with Suspected Epilepsy Using a Digital EEG Biomarker
Lengthy waits for follow-up testing are common for people with suspected epilepsy. This delays diagnosis, prolongs uncertainty and increases seizure risk. Initial EEGs are frequently inconclusive, yet follow-ups are often dictated by referral date, and there is no established method for risk-based prioritisation. Here, we tested whether an established digital EEG biomarker could help prioritise those most likely to have epilepsy for expedited follow-up EEG testing. We analysed 196 normal non-contributory (non-diagnostic) initial EEGs collected from six National Health Service (NHS) sites in England. From these recordings, we extracted eight previously validated computational features that quantify the likelihood that the EEG was recorded from someone with active epilepsy. We then used this information to reorder follow-up lists and compared outcomes against standard referral-based scheduling. We found that ordering for follow-up testing based upon the digital biomarker consistently prioritised people subsequently diagnosed with epilepsy; for a waitlist of 40 patients, the median number of follow-up EEGs needed to see 50% of true epilepsy patients was decreased by 6 (95% CI 4-7). The EEG diagnostic yield for epilepsy of follow-ups was increased relative to orderings based on time of referral (median increase in yield for epilepsy at 50% follow-up EEGs was 5%; 95 CI 4.9%-10%). Our study indicates that a routine EEG may furnish an objective risk metric that could accelerate second-line investigations and so reduce diagnostic delay whilst improving resource allocation in clinical practice.
- Open Access
- 19 September 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e60129
A Digital Intervention for Capturing the Real-Time Health Data Needed for Epilepsy Seizure Forecasting: Protocol for a Formative Co-Design and Usability Study (The ATMOSPHERE Study)
Background: Epilepsy is a chronic neurological disorder affecting individuals globally, marked by recurrent and apparently unpredictable seizures that pose significant challenges, including increased mortality, injuries, and diminished quality of life. Despite advancements in treatments, a significant proportion of people with epilepsy continue to experience uncontrolled seizures. The apparent unpredictability of these events has been identified as a major concern for people with epilepsy, highlighting the need for innovative seizure forecasting technologies. Objective: The ATMOSPHERE study aimed to develop and evaluate a digital intervention, using wearable technology and data science, that provides real-time, individualized seizure forecasting for individuals living with epilepsy. This paper reports the protocol for one of the workstreams focusing on the design and testing of a prototype to capture real-time input data needed for predictive modeling. The first aim was to collaboratively design the prototype (work completed). The second aim is to conduct an “in-the-wild” study to assess usability and refine the prototype (planned research). Methods: This study uses a person-based approach to design and test the usability of a prototype for real-time seizure precipitant data capture. Phase 1 (work completed) involved co-design with individuals living with epilepsy and health care professionals. Sessions explored users’ requirements for the prototype, followed by iterative design of low-fidelity, static prototypes. Phase 2 (planned research) will be an “in-the-wild” usability study involving the deployment of a mid-fidelity, functional prototype for 4 weeks, with the collection of mixed methods usability data to assess the prototype’s real-world application, feasibility, acceptability, and engagement. This phase involves primary participants (adults diagnosed with epilepsy) and, optionally, their nominated significant other. The usability study will run in 3 rounds of deployment and data collection, aiming to recruit 5 participants per round, with prototype refinement between rounds. Results: The phase-1 co-design study engaged 22 individuals, resulting in the development of a mid-fidelity, functional prototype based on identified requirements, including the tracking of evidence-based and personalized seizure precipitants. The upcoming phase-2 usability study is expected to provide insights into the prototype’s real-world usability, identify areas for improvement, and refine the technology for future development. The estimated completion date of phase 2 is the last quarter of 2024. Conclusions: The ATMOSPHERE study aims to make a significant step forward in epilepsy management, focusing on the development of a user-centered, noninvasive wearable device for seizure forecasting. Through a collaborative design process and comprehensive usability testing, this research aims to address the critical need for predictive seizure forecasting technologies, offering a promising approach to improving the lives of individuals with epilepsy. By leveraging predictive analytics and personalized machine learning models, this technology seeks to offer a novel approach to managing epilepsy, potentially improving clinical outcomes, including quality of life, through increased predictability and seizure management. International Registered Report Identifier (IRRID): DERR1-10.2196/60129
- 19 September 2024
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 13 (1) , e60129
Open AccessA Digital Intervention for Capturing the Real-Time Health Data Needed for Epilepsy Seizure Forecasting: Protocol for a Formative Co-Design and Usability Study (The ATMOSPHERE Study)
Background: Epilepsy is a chronic neurological disorder affecting individuals globally, marked by recurrent and apparently unpredictable seizures that pose significant challenges, including increased mortality, injuries, and diminished quality of life. Despite advancements in treatments, a significant proportion of people with epilepsy continue to experience uncontrolled seizures. The apparent unpredictability of these events has been identified as a major concern for people with epilepsy, highlighting the need for innovative seizure forecasting technologies. Objective: The ATMOSPHERE study aimed to develop and evaluate a digital intervention, using wearable technology and data science, that provides real-time, individualized seizure forecasting for individuals living with epilepsy. This paper reports the protocol for one of the workstreams focusing on the design and testing of a prototype to capture real-time input data needed for predictive modeling. The first aim was to collaboratively design the prototype (work completed). The second aim is to conduct an “in-the-wild” study to assess usability and refine the prototype (planned research). Methods: This study uses a person-based approach to design and test the usability of a prototype for real-time seizure precipitant data capture. Phase 1 (work completed) involved co-design with individuals living with epilepsy and health care professionals. Sessions explored users’ requirements for the prototype, followed by iterative design of low-fidelity, static prototypes. Phase 2 (planned research) will be an “in-the-wild” usability study involving the deployment of a mid-fidelity, functional prototype for 4 weeks, with the collection of mixed methods usability data to assess the prototype’s real-world application, feasibility, acceptability, and engagement. This phase involves primary participants (adults diagnosed with epilepsy) and, optionally, their nominated significant other. The usability study will run in 3 rounds of deployment and data collection, aiming to recruit 5 participants per round, with prototype refinement between rounds. Results: The phase-1 co-design study engaged 22 individuals, resulting in the development of a mid-fidelity, functional prototype based on identified requirements, including the tracking of evidence-based and personalized seizure precipitants. The upcoming phase-2 usability study is expected to provide insights into the prototype’s real-world usability, identify areas for improvement, and refine the technology for future development. The estimated completion date of phase 2 is the last quarter of 2024. Conclusions: The ATMOSPHERE study aims to make a significant step forward in epilepsy management, focusing on the development of a user-centered, noninvasive wearable device for seizure forecasting. Through a collaborative design process and comprehensive usability testing, this research aims to address the critical need for predictive seizure forecasting technologies, offering a promising approach to improving the lives of individuals with epilepsy. By leveraging predictive analytics and personalized machine learning models, this technology seeks to offer a novel approach to managing epilepsy, potentially improving clinical outcomes, including quality of life, through increased predictability and seizure management. International Registered Report Identifier (IRRID): DERR1-10.2196/60129
- Open Access
- 13 May 2024
- Published by JMIR Publications Inc. in JMIR Preprints
A Digital Intervention for Capturing the Real-Time Health Data Needed for Epilepsy Seizure Forecasting: Protocol for a Formative Co-Design and Usability Study (The ATMOSPHERE Study) (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Epilepsy is a chronic neurological disorder affecting individuals globally, marked by recurrent and apparently unpredictable seizures that pose significant challenges, including increased mortality, injuries, and diminished quality of life. Despite advancements in treatments, a significant proportion of people with epilepsy continue to experience uncontrolled seizures. The apparent unpredictability of these events has been identified as a major concern for people with epilepsy, highlighting the need for innovative seizure forecasting technologies. Objective: The ATMOSPHERE study aimed to develop and evaluate a digital intervention, using wearable technology and data science, that provides real-time, individualized seizure forecasting for individuals living with epilepsy. This paper reports the protocol for one of the workstreams focusing on the design and testing of a prototype to capture real-time input data needed for predictive modeling. The first aim was to collaboratively design the prototype (work completed). The second aim is to conduct an “in-the-wild” study to assess usability and refine the prototype (planned research). Methods: This study uses a person-based approach to design and test the usability of a prototype for real-time seizure precipitant data capture. Phase 1 (work completed) involved co-design with individuals living with epilepsy and health care professionals. Sessions explored users’ requirements for the prototype, followed by iterative design of low-fidelity, static prototypes. Phase 2 (planned research) will be an “in-the-wild” usability study involving the deployment of a mid-fidelity, functional prototype for 4 weeks, with the collection of mixed methods usability data to assess the prototype’s real-world application, feasibility, acceptability, and engagement. This phase involves primary participants (adults diagnosed with epilepsy) and, optionally, their nominated significant other. The usability study will run in 3 rounds of deployment and data collection, aiming to recruit 5 participants per round, with prototype refinement between rounds. Results: The phase-1 co-design study engaged 22 individuals, resulting in the development of a mid-fidelity, functional prototype based on identified requirements, including the tracking of evidence-based and personalized seizure precipitants. The upcoming phase-2 usability study is expected to provide insights into the prototype’s real-world usability, identify areas for improvement, and refine the technology for future development. The estimated completion date of phase 2 is the last quarter of 2024. Conclusions: The ATMOSPHERE study aims to make a significant step forward in epilepsy management, focusing on the development of a user-centered, noninvasive wearable device for seizure forecasting. Through a collaborative design process and comprehensive usability testing, this research aims to address the critical need for predictive seizure forecasting technologies, offering a promising approach to improving the lives of individuals with epilepsy. By leveraging predictive analytics and personalized machine learning models, this technology seeks to offer a novel approach to managing epilepsy, potentially improving clinical outcomes, including quality of life, through increased predictability and seizure management.
- 13 May 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Digital Intervention for Capturing the Real-Time Health Data Needed for Epilepsy Seizure Forecasting: Protocol for a Formative Co-Design and Usability Study (The ATMOSPHERE Study) (Preprint)
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Epilepsy is a chronic neurological disorder affecting individuals globally, marked by recurrent and apparently unpredictable seizures that pose significant challenges, including increased mortality, injuries, and diminished quality of life. Despite advancements in treatments, a significant proportion of people with epilepsy continue to experience uncontrolled seizures. The apparent unpredictability of these events has been identified as a major concern for people with epilepsy, highlighting the need for innovative seizure forecasting technologies. Objective: The ATMOSPHERE study aimed to develop and evaluate a digital intervention, using wearable technology and data science, that provides real-time, individualized seizure forecasting for individuals living with epilepsy. This paper reports the protocol for one of the workstreams focusing on the design and testing of a prototype to capture real-time input data needed for predictive modeling. The first aim was to collaboratively design the prototype (work completed). The second aim is to conduct an “in-the-wild” study to assess usability and refine the prototype (planned research). Methods: This study uses a person-based approach to design and test the usability of a prototype for real-time seizure precipitant data capture. Phase 1 (work completed) involved co-design with individuals living with epilepsy and health care professionals. Sessions explored users’ requirements for the prototype, followed by iterative design of low-fidelity, static prototypes. Phase 2 (planned research) will be an “in-the-wild” usability study involving the deployment of a mid-fidelity, functional prototype for 4 weeks, with the collection of mixed methods usability data to assess the prototype’s real-world application, feasibility, acceptability, and engagement. This phase involves primary participants (adults diagnosed with epilepsy) and, optionally, their nominated significant other. The usability study will run in 3 rounds of deployment and data collection, aiming to recruit 5 participants per round, with prototype refinement between rounds. Results: The phase-1 co-design study engaged 22 individuals, resulting in the development of a mid-fidelity, functional prototype based on identified requirements, including the tracking of evidence-based and personalized seizure precipitants. The upcoming phase-2 usability study is expected to provide insights into the prototype’s real-world usability, identify areas for improvement, and refine the technology for future development. The estimated completion date of phase 2 is the last quarter of 2024. Conclusions: The ATMOSPHERE study aims to make a significant step forward in epilepsy management, focusing on the development of a user-centered, noninvasive wearable device for seizure forecasting. Through a collaborative design process and comprehensive usability testing, this research aims to address the critical need for predictive seizure forecasting technologies, offering a promising approach to improving the lives of individuals with epilepsy. By leveraging predictive analytics and personalized machine learning models, this technology seeks to offer a novel approach to managing epilepsy, potentially improving clinical outcomes, including quality of life, through increased predictability and seizure management.